Related Experiment Video
Updated: Jan 16, 2026

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
Published on: August 15, 2019
Two Japanese families with adult-onset leukoencephalopathy caused by pathogenic variants in CST3
Kenta Orimo1, Takashi Matsukawa2, Kazutaka Shiomi3
1Department of Precision Medicine Neurology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.
Insights
Cystatin C (CST3) gene variants can cause adult-onset leukoencephalopathy. This study identifies a novel CST3 variant leading to an in-frame deletion, expanding the known genetic causes of this neurological disorder.
Area of Science:
- Genetics
- Neurology
- Molecular Biology
Background:
- Cystatin C (CST3) gene variants are linked to adult-onset leukoencephalopathy.
- Clinical features include headaches, transient neurological symptoms, and specific imaging findings.
Purpose of the Study:
- To investigate the clinical and genetic spectrum of CST3-related leukoencephalopathy.
- To characterize a novel CST3 variant and its associated molecular mechanism.
Main Methods:
- Clinical evaluation of four patients from two Japanese families.
- Genetic analysis including sequencing and mRNA analysis.
- Variant classification and functional impact assessment.
Main Results:
- Identified four patients with CST3-related leukoencephalopathy.
- Described a novel CST3 variant (c.358-2_395del) in one patient.
- mRNA analysis revealed a splicing alteration causing an in-frame deletion (p.Lys120_Gln133del), the first non-truncating CST3 variant.
Conclusions:
- The findings broaden the understanding of CST3-related leukoencephalopathy's clinical and genetic diversity.
- This study highlights a novel non-truncating variant expanding the pathogenic mechanisms for this condition.
Abstract:
CST3 (NM_000099.4) encodes cystatin C, whose C-terminal truncating variants in this gene have recently been reported to cause adult-onset leukoencephalopathy, characterized by headaches, transient neurological symptoms, and distinct imaging findings. We present four patients from two Japanese families, including one with a novel variant (c.358-2_395del). Three patients from one family developed chronic headaches around the age of 20, whereas the patient from the other family remained asymptomatic until his fifties. mRNA analysis of the patient with c.358-2_395del revealed a splicing alteration leading to an in-frame deletion (p.Lys120_Gln133del), representing the first CST3 variant that does not result in a truncated protein. These findings broaden our understanding of the clinical and genetic spectra of CST3-related leukoencephalopathy (114 words).
More Related Videos
Related Concept Videos
Translation
Translation Produces the Building Blocks of Life
Proteins are...
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Sex-linked Disorders
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Animal Mitochondrial Genetics

